Guest:
Sultan Meghji, VP Product Strategy, Appistry Bio and Contact Info
Podcast Sponsor: Ingenuity - iReport, the fastest and most accurate way to get biological meaning from your expression data. Upload your data and get a free iReport analysis summary at www.ingenuity.com/get iReport/
Listen (3:01) Formative years with geneticist father
Listen (4:55) Appistry, new to life science
Listen (7:17) Regulation and security issues
Listen (4:43) Roche move on Illumina
Listen (7:26) We haven't scratched the surface of genomics
Listen (8:12) Human de novo sequencing
Listen (0:46) Emerging sequencing technologies
Listen (6:24) Sequencing still the bottleneck, not analysis
Listen (1:53) No more blockbuster drugs
Sultan Meghji is the Vice President of Product Strategy at Appistry, a company working to develop the infrastructure needed to deliver medically actionable genetic data that can be applied to individual patients. Meghji has spent more than 20 years studying the technical aspects and business applications of high performance computing. He started his career at the National Center for Supercomputing Applications (NCSA), where he developed artificial intelligence systems and Internet technologies. From there, Meghji moved into several IT leadership positions at ABN AMRO, American Express, Monsanto, United Airlines, as well as in academia.
